26-28 February, 2019

London, UK
Twitter logo for website footers 2

For the second year, the CAR-TCR Summit Europe returns as the premier industry dedicated summit focused on the delivery of safe and effective next generation CAR or TCR driven cell immunotherapies to patients in Europe.

With two newly approved CAR-T therapies in Europe and the race to market stronger than ever, join the CAR-TCR community to:

  • Share expertise on strategies to navigate the complex regulations and reimbursement landscape to understand and overcome market access challenges
  • Hear novel scientific innovations with various cell types, combination therapies and genetic engineering to enhance efficacy in solid tumour indications

Seize your opportunity to network with 200 leading experts in European CAR-TCR therapy, and join the discussion on strategies to reduce cost of goods and streamline manufacturing with allogeneic developments.

Leave with tangible takeaways you need to help implement your strategy and pipeline to deliver safe and effective curative therapies to patients in need.

Register your interest now to receive the finalised agenda.

"One of the most effective conferences in the very complex and fast evolving field of CAR-TCR cell therapy."

-Paolo, GammaDelta Therapeutics

"I can't speak highly enough about this conference.  This conference allowed me to keep informed of the latest research and development on T cell therapies.  I was also able to network with some of the leaders in T cell immunotherapies from both academia and the industry."

-Arnab Ghosh, Hematology & Medical Oncology Fellow, MSKCC, CAR-TCR 2017 attendee